TODD DAVIS
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
MARK AMBROSE, GREGORY BROWN, GREGORY B. BROWN, WARREN D. COOPER, TODD C. DAVIS, VITHALBHAI D. DHADUK, WENDY DICICCO, CPA, WENDY DICOCCO, CPA, RICHARD DINOVITZ, SHANKAR MUSUNURI, MUKESHBHAI PATEL, MATTHEW Q. REBER, ANDREW ROMBERGER, ESQ., ANDREW L. ROMBERGER, ESQ., VIJAY TAMMARA, PH.D., DAVID ZENG, PH.D.
DIRECTOR
DIRECTOR
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
DIRECTOR
CLAYTON ADAMS, PETER BORISH, JOHN DORSEY, GREG ECONOMOU, DENNIS GILE, JEFFRY HECKLINSKI, GLEN KIM, MARTIN LANPHERE, ROGER MASON, ROGER MASON JR., DANIEL NELSON, DANIEL D. NELSON, DAVID O-HARA, DAMON RICH, RON SASLOW, CRAIG SMITH, NOAH SMITH, RICHARD SYMINGTON, TRENT WHITEHEAD, TIM WICKS, DAVID WOLFSON, CHRISTAIN YOUNG
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2025-11-06
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-07-01
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Debt
2024-07-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-12-16
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-01-08

